Log In
Print this Print this

resveratrol (SRT501)

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionOrally bioavailable formulation of resveratrol that activates SIRT1
Molecular Target Sirtuin 1 (SIRT1)
Mechanism of ActionSirtuin 1 (SIRT1) activator
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today